Candida albicans shunt infection

S. Shapiro, T. Javed, J. Mealey

Research output: Contribution to journalArticle

18 Scopus citations

Abstract

Seven cases of successfully treated Candida albicans cerebrospinal fluid shunt infections are reported. Treatment consisted of shunt removal and intravenous Amphoteracin B in all cases and intraventricular Amphoteracin B in 4 cases. Serious underlying medical illness, recent antibiotic therapy, indwelling intravascular and/or Foley catheters, coincident candidiasis and low birth weight prematurity are major risk factors for candida shunt infection. Candida shunt infection appears to occur by either contamination at the time of shunt placement or by hematogenous dissemination.

Original languageEnglish (US)
Pages (from-to)125-130
Number of pages6
JournalPediatric Neuroscience
Volume15
Issue number3
StatePublished - Dec 1 1989

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Candida albicans shunt infection'. Together they form a unique fingerprint.

  • Cite this

    Shapiro, S., Javed, T., & Mealey, J. (1989). Candida albicans shunt infection. Pediatric Neuroscience, 15(3), 125-130.